tiprankstipranks
Cardiff Oncology, Inc. (CRDF)
NASDAQ:CRDF
US Market
CRDF
Cardiff Oncology
RESEARCH TOOLSreports
Want to see CRDF full AI Analyst Report?

Cardiff Oncology (CRDF) Income Statement

1,980 Followers

Cardiff Oncology Income Statement

Last quarter (Q4 2025), Cardiff Oncology's total revenue was $243.00K, an increase of 60.93% from the same quarter last year. In Q4, Cardiff Oncology's net income was $-7.22M. See Cardiff Oncology’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 593.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Gross Profit
$ -311.00K$ 683.00K$ 488.00K$ 386.00K$ 359.00K
Operating Expenses
$ 48.65M$ 49.33M$ 45.90M$ 40.29M$ 29.21M
Depreciation and Amortization
$ 904.00K$ 404.00K$ 398.00K$ 236.00K$ 451.00K
EBITDA
$ -44.97M$ -48.25M$ -45.01M$ -39.67M$ -28.40M
Operating Income
$ -48.96M$ -48.65M$ -45.41M$ -39.90M$ -28.86M
Other Income/Expenses
$ 3.11M$ 3.22M$ 3.97M$ 1.20M$ 564.00K
Pretax Income
$ -45.88M$ -45.43M$ -41.44M$ -38.70M$ -28.29M
Net Income
$ -45.88M$ -45.43M$ -41.44M$ -38.70M$ -28.29M
Per Share Metrics
Basic EPS
$ -0.69$ -0.95$ -0.93$ -0.89$ -0.73
Diluted EPS
$ -0.69$ -0.95$ -0.93$ -0.89$ -0.73
Weighted Average Shares Outstanding
 66.84M 47.65M 44.68M 43.60M 39.03M
Weighted Average Shares Outstanding (Diluted)
 66.84M 47.65M 44.68M 43.60M 39.03M
Currency in USD

Cardiff Oncology Earnings and Revenue History